Skip to content

CytoDyn on go with UK late-stage study of leronlimab for COVID-19

August 20, 2020

The UK’s Medicines and Healthcare products Regulatory Agency has signed off on a Phase 3 clinical trial evaluating CytoDyn’s (OTCQB:CYDY) leronlimab in severely ill and critically ill COVID-19 patients.

Yesterday, it requested Fast Track approval of the drug based on the results from a mid-stage study.

https://seekingalpha.com/news/3607345-cytodyn-on-go-uk-late-stage-study-of-leronlimab-for-covidminus-19

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: